What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Myocardial infarction
George Dangas mostly deals with Internal medicine, Cardiology, Surgery, Percutaneous coronary intervention and Myocardial infarction.
Internal medicine is a component of his Conventional PCI, Angioplasty, Randomized controlled trial, Stent and TIMI studies.
His Cardiology research includes themes of Stroke, Percutaneous and Hazard ratio.
His Surgery research includes elements of Incidence, Valve replacement and Risk factor.
His work deals with themes such as Creatinine, Nephropathy and Renal function, which intersect with Percutaneous coronary intervention.
George Dangas has researched Myocardial infarction in several fields, including Bypass surgery and Cardiac catheterization.
His most cited work include:
- A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation (1605 citations)
- Bivalirudin during Primary PCI in Acute Myocardial Infarction (1565 citations)
- Strategies for Multivessel Revascularization in Patients with Diabetes (1215 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Cardiology, Percutaneous coronary intervention, Conventional PCI and Myocardial infarction.
His Internal medicine study frequently intersects with other fields, such as Surgery.
His research in the fields of Angioplasty, Bivalirudin and Acute coronary syndrome overlaps with other disciplines such as In patient.
His Percutaneous coronary intervention study incorporates themes from Diabetes mellitus, Emergency medicine, Clopidogrel, Aspirin and Hazard ratio.
His Conventional PCI research is multidisciplinary, incorporating perspectives in Single Center and Cohort.
His Myocardial infarction research is multidisciplinary, relying on both Prospective cohort study and Incidence.
He most often published in these fields:
- Internal medicine (69.51%)
- Cardiology (59.59%)
- Percutaneous coronary intervention (40.13%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (69.51%)
- Cardiology (59.59%)
- Percutaneous coronary intervention (40.13%)
In recent papers he was focusing on the following fields of study:
George Dangas mainly focuses on Internal medicine, Cardiology, Percutaneous coronary intervention, Conventional PCI and Myocardial infarction.
When carried out as part of a general Internal medicine research project, his work on Stroke, Coronary artery disease, Randomized controlled trial and Acute coronary syndrome is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
His research in Cardiology intersects with topics in Acute kidney injury and Meta-analysis.
His biological study spans a wide range of topics, including Aspirin, Adverse effect, Incidence and Hazard ratio.
His Conventional PCI study combines topics from a wide range of disciplines, such as Prospective cohort study, Single Center and Emergency medicine.
The concepts of his Myocardial infarction study are interwoven with issues in Stent and Clinical endpoint.
Between 2017 and 2021, his most popular works were:
- Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial (256 citations)
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI (255 citations)
- Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. (134 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
